{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:08:49Z","timestamp":1794564529776,"version":"4.9.1"},"reference-count":103,"publisher":"European Respiratory Society (ERS)","issue":"166","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2022,9,18]]},"published-print":{"date-parts":[[2022,12,31]]},"abstract":"<jats:p>\n                    <jats:italic>Aspergillus<\/jats:italic>\n                    species are the most frequent cause of fungal infections of the lungs with a broad spectrum of clinical presentations including invasive pulmonary aspergillosis (IPA) and chronic pulmonary aspergillosis (CPA). IPA affects immunocompromised populations, which are increasing in number and diversity with the advent of novel anti-cancer therapies. Moreover, IPA has emerged as a complication of severe influenza and coronavirus disease 2019 in apparently immunocompetent hosts. CPA mainly affects patients with pre-existing lung lesions and is recognised increasingly frequently among patients with long-term survival following cure of tuberculosis or lung cancer. The diagnosis of pulmonary aspergillosis is complex as it relies on the presence of clinical, radiological and microbiological criteria, which differ according to the type of pulmonary aspergillosis (IPA or CPA) and the type of patient population. The management of pulmonary aspergillosis is complicated by the limited number of treatment options, drug interactions, adverse events and the emergence of antifungal resistance.\n                  <\/jats:p>","DOI":"10.1183\/16000617.0114-2022","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T03:56:13Z","timestamp":1669780573000},"page":"220114","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":147,"title":["Pulmonary aspergillosis: diagnosis and treatment"],"prefix":"10.1183","volume":"31","author":[{"given":"Frederic","family":"Lamoth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Calandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"2024102404080792000_31.166.220114.1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/jof2020017","article-title":"Allergic bronchopulmonary aspergillosis","volume":"2","author":"Tracy","year":"2016","journal-title":"J Fungi"},{"key":"2024102404080792000_31.166.220114.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00583-2015"},{"key":"2024102404080792000_31.166.220114.3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.idc.2021.03.008","article-title":"Aspergillosis: epidemiology, diagnosis, and treatment","volume":"35","author":"Cadena","year":"2021","journal-title":"Infect Dis Clin North Am"},{"key":"2024102404080792000_31.166.220114.4","doi-asserted-by":"crossref","first-page":"e3606","DOI":"10.1093\/cid\/ciaa1065","article-title":"Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study","volume":"73","author":"Bartoletti","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024102404080792000_31.166.220114.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200401-093OC"},{"key":"2024102404080792000_31.166.220114.6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024102404080792000_31.166.220114.7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.012054"},{"key":"2024102404080792000_31.166.220114.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.08.003"},{"key":"2024102404080792000_31.166.220114.9","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024102404080792000_31.166.220114.10","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/cid\/ciaa1855","article-title":"Guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: from the imaging working group for the revision and update of the consensus definitions of fungal disease from the EORTC\/MSGERC","volume":"72","author":"Alexander","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024102404080792000_31.166.220114.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2014.02.006"},{"key":"2024102404080792000_31.166.220114.12","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx030"},{"key":"2024102404080792000_31.166.220114.13","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05316-11"},{"key":"2024102404080792000_31.166.220114.14","doi-asserted-by":"publisher","DOI":"10.1086\/651263"},{"key":"2024102404080792000_31.166.220114.15","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12981"},{"key":"2024102404080792000_31.166.220114.16","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1080\/10428194.2016.1204652","article-title":"Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study","volume":"58","author":"Mariette","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"2024102404080792000_31.166.220114.17","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"2024102404080792000_31.166.220114.18","doi-asserted-by":"publisher","DOI":"10.1086\/522189"},{"key":"2024102404080792000_31.166.220114.19","doi-asserted-by":"crossref","first-page":"ofab174","DOI":"10.1093\/ofid\/ofab174","article-title":"Limited index of clinical suspicion and underdiagnosis of histopathologically documented invasive mold infections","volume":"8","author":"Caudron de Coquereaumont","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2024102404080792000_31.166.220114.20","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.303"},{"key":"2024102404080792000_31.166.220114.21","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s00277-021-04622-9","article-title":"Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia\/lymphoma exposed to zidovudine and interferon alfa","volume":"100","author":"Guery","year":"2021","journal-title":"Ann Hematol"},{"key":"2024102404080792000_31.166.220114.22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix687"},{"key":"2024102404080792000_31.166.220114.23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.1.253"},{"key":"2024102404080792000_31.166.220114.24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/myc.12755","article-title":"Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients","volume":"61","author":"Couchepin","year":"2018","journal-title":"Mycoses"},{"key":"2024102404080792000_31.166.220114.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01159-9"},{"key":"2024102404080792000_31.166.220114.26","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2508"},{"key":"2024102404080792000_31.166.220114.27","doi-asserted-by":"publisher","DOI":"10.1086\/595846"},{"key":"2024102404080792000_31.166.220114.28","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ555"},{"key":"2024102404080792000_31.166.220114.29","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00942-12"},{"key":"2024102404080792000_31.166.220114.30","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2013.804033"},{"key":"2024102404080792000_31.166.220114.31","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/cid\/ciaa1943","article-title":"Assessment of the role of 1,3-beta-d-glucan testing for the diagnosis of invasive fungal infections in adults","volume":"72","author":"Lamoth","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024102404080792000_31.166.220114.32","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cid\/ciab1028","article-title":"High false-positive rate of (1,3)-beta-d-glucan in onco-hematological patients receiving immunoglobulins and therapeutic antibodies","volume":"75","author":"Tschopp","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2024102404080792000_31.166.220114.33","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326"},{"key":"2024102404080792000_31.166.220114.34","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2024102404080792000_31.166.220114.35","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu673"},{"key":"2024102404080792000_31.166.220114.36","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12898"},{"key":"2024102404080792000_31.166.220114.37","doi-asserted-by":"publisher","DOI":"10.1086\/651262"},{"key":"2024102404080792000_31.166.220114.38","doi-asserted-by":"publisher","DOI":"10.1086\/503427"},{"key":"2024102404080792000_31.166.220114.39","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01183-10"},{"key":"2024102404080792000_31.166.220114.40","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3389\/fmicb.2018.01877","article-title":"Aspergillus PCR in bronchoalveolar lavage fluid for the diagnosis and prognosis of aspergillosis in patients with hematological and non-hematological conditions","volume":"9","author":"Imbert","year":"2018","journal-title":"Front Microbiol"},{"key":"2024102404080792000_31.166.220114.41","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir185"},{"key":"2024102404080792000_31.166.220114.42","first-page":"1631","article-title":"Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): a comparison with influenza associated aspergillosis (IAPA)","volume":"224","author":"Lamoth","year":"2021","journal-title":"J Infect Dis"},{"key":"2024102404080792000_31.166.220114.43","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S2666-5247(21)00091-4","article-title":"Invasive mould disease in fatal COVID-19: a systematic review of autopsies","volume":"2","author":"Kula","year":"2021","journal-title":"Lancet Microbe"},{"key":"2024102404080792000_31.166.220114.44","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000504"},{"key":"2024102404080792000_31.166.220114.45","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.cmi.2021.06.025","article-title":"COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?","volume":"27","author":"Fekkar","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2024102404080792000_31.166.220114.46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QCO.0000000000000812","article-title":"Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians","volume":"35","author":"Lamoth","year":"2022","journal-title":"Curr Opin Infect Dis"},{"key":"2024102404080792000_31.166.220114.47","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3109\/00365548.2013.797598","article-title":"Aspergillus sp. isolated in critically ill patients with extracorporeal membrane oxygenation support","volume":"45","author":"Aubron","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"2024102404080792000_31.166.220114.48","doi-asserted-by":"crossref","first-page":"myab064","DOI":"10.1093\/mmy\/myab064","article-title":"Aspergillosis: emerging risk groups in critically ill patients","volume":"60","author":"Kluge","year":"2021","journal-title":"Med Mycol"},{"key":"2024102404080792000_31.166.220114.49","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(20)30847-1"},{"key":"2024102404080792000_31.166.220114.50","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06091-6"},{"key":"2024102404080792000_31.166.220114.51","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201111-1978OC"},{"key":"2024102404080792000_31.166.220114.52","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cmi.2019.11.019","article-title":"High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum","volume":"26","author":"Vergidis","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2024102404080792000_31.166.220114.53","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/myc.13052","article-title":"Positive Aspergillus PCR as a marker of azole resistance or sub-therapeutic antifungal therapy in patients with chronic pulmonary aspergillosis","volume":"63","author":"Moazam","year":"2020","journal-title":"Mycoses"},{"key":"2024102404080792000_31.166.220114.54","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3109\/13693786.2012.682228","article-title":"Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis","volume":"50","author":"Izumikawa","year":"2012","journal-title":"Med Mycol"},{"key":"2024102404080792000_31.166.220114.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.04.007"},{"key":"2024102404080792000_31.166.220114.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.01.005"},{"key":"2024102404080792000_31.166.220114.57","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-003-0970-y"},{"key":"2024102404080792000_31.166.220114.58","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/cid\/ciab1070","article-title":"Investigational antifungal agents for invasive mycoses: a clinical perspective","volume":"75","author":"Lamoth","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2024102404080792000_31.166.220114.59","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/jof6020084","article-title":"Clinical relevance and characteristics of Aspergillus calidoustus and other Aspergillus species of section Usti","volume":"6","author":"Glampedakis","year":"2020","journal-title":"J Fungi"},{"key":"2024102404080792000_31.166.220114.60","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00683"},{"key":"2024102404080792000_31.166.220114.61","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","article-title":"Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial","volume":"397","author":"Maertens","year":"2021","journal-title":"Lancet"},{"key":"2024102404080792000_31.166.220114.62","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2017.1391213"},{"key":"2024102404080792000_31.166.220114.63","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1080\/10428194.2019.1639165","article-title":"QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia","volume":"60","author":"Barreto","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"2024102404080792000_31.166.220114.64","doi-asserted-by":"publisher","DOI":"10.1086\/524669"},{"key":"2024102404080792000_31.166.220114.65","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis437"},{"key":"2024102404080792000_31.166.220114.66","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/myc.13293","article-title":"The influence of CYP2C19 polymorphisms on voriconazole trough concentrations: systematic review and meta-analysis","volume":"64","author":"Zhang","year":"2021","journal-title":"Mycoses"},{"key":"2024102404080792000_31.166.220114.67","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01034-08"},{"key":"2024102404080792000_31.166.220114.68","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01306-y"},{"key":"2024102404080792000_31.166.220114.69","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00585-18"},{"key":"2024102404080792000_31.166.220114.70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/jof6040209","article-title":"Isavuconazole-animal data and clinical data","volume":"6","author":"Pagano","year":"2020","journal-title":"J Fungi"},{"key":"2024102404080792000_31.166.220114.71","doi-asserted-by":"publisher","DOI":"10.3201\/eid2106.140717"},{"key":"2024102404080792000_31.166.220114.72","doi-asserted-by":"publisher","DOI":"10.3201\/eid2607.200088"},{"key":"2024102404080792000_31.166.220114.73","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy859"},{"key":"2024102404080792000_31.166.220114.74","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0069-4"},{"key":"2024102404080792000_31.166.220114.75","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00978-17"},{"key":"2024102404080792000_31.166.220114.76","doi-asserted-by":"crossref","first-page":"e0227421","DOI":"10.1128\/aac.02274-21","article-title":"Aspergillus terreus and the interplay with amphotericin B: from resistance to tolerance?","volume":"66","author":"Vahedi-Shahandashti","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2024102404080792000_31.166.220114.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2006.01.001"},{"key":"2024102404080792000_31.166.220114.78","first-page":"CD010481","article-title":"Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function","volume":"2015","author":"Botero Aguirre","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102404080792000_31.166.220114.79","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.2473063.x"},{"key":"2024102404080792000_31.166.220114.80","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020191"},{"key":"2024102404080792000_31.166.220114.81","doi-asserted-by":"publisher","DOI":"10.1086\/514341"},{"key":"2024102404080792000_31.166.220114.82","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00399-19"},{"key":"2024102404080792000_31.166.220114.83","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/jof6040192","article-title":"Review of the novel echinocandin antifungal rezafungin: animal studies and clinical data","volume":"6","author":"Zhao","year":"2020","journal-title":"J Fungi"},{"key":"2024102404080792000_31.166.220114.84","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01277-17"},{"key":"2024102404080792000_31.166.220114.85","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12477"},{"key":"2024102404080792000_31.166.220114.86","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.8.2564-2568.2002"},{"key":"2024102404080792000_31.166.220114.87","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.9.3039-3041.2002"},{"key":"2024102404080792000_31.166.220114.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2015.08.001"},{"key":"2024102404080792000_31.166.220114.89","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23109"},{"key":"2024102404080792000_31.166.220114.90","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00259-018-4192-z","article-title":"Role of FDG PET\/CT in monitoring treatment response in patients with invasive fungal infections","volume":"46","author":"Ankrah","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024102404080792000_31.166.220114.91","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12075"},{"key":"2024102404080792000_31.166.220114.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2005.08.022"},{"key":"2024102404080792000_31.166.220114.93","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-012-0322-x"},{"key":"2024102404080792000_31.166.220114.94","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2015.1102053"},{"key":"2024102404080792000_31.166.220114.95","first-page":"688","article-title":"Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study","volume":"49","author":"Kohno","year":"2011","journal-title":"Med Mycol"},{"key":"2024102404080792000_31.166.220114.96","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1784"},{"key":"2024102404080792000_31.166.220114.97","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/jof6030096","article-title":"CPAnet registry\u2013an international chronic pulmonary aspergillosis registry","volume":"6","author":"Laursen","year":"2020","journal-title":"J Fungi"},{"key":"2024102404080792000_31.166.220114.98","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007394.pub2"},{"key":"2024102404080792000_31.166.220114.99","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70019-2"},{"key":"2024102404080792000_31.166.220114.100","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0488"},{"key":"2024102404080792000_31.166.220114.101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043347"},{"key":"2024102404080792000_31.166.220114.102","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012399.pub2"},{"key":"2024102404080792000_31.166.220114.103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028467"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0114-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:05:37Z","timestamp":1740355537000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0114-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":103,"journal-issue":{"issue":"166","published-online":{"date-parts":[[2022,11,29]]},"published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1183\/16000617.0114-2022"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0114-2022","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]}}}